Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Inventory (2024 - 2025)

X4 Pharmaceuticals' Inventory history spans 2 years, with the latest figure at $4.5 million for Q4 2025.

  • For Q4 2025, Inventory rose 59.0% year-over-year to $4.5 million; the TTM value through Dec 2025 reached $4.5 million, up 59.0%, while the annual FY2025 figure was $4.5 million, 59.0% up from the prior year.
  • Inventory reached $4.5 million in Q4 2025 per XFOR's latest filing, up from $4.1 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $4.5 million in Q4 2025 to a low of $831000.0 in Q2 2024.